Anti-CD20 (rituximab) therapy for anti-IFN-γ autoantibody-associated nontuberculous mycobacterial infection.
Browne SK, Zaman R, Sampaio EP, Jutivorakool K, Rosen LB, Ding L, Pancholi MJ, Yang LM, Priel DL, Uzel G, Freeman AF, Hayes CE, Baxter R, Cohen SH, Holland SM.
Browne SK, et al. Among authors: uzel g.
Blood. 2012 Apr 26;119(17):3933-9. doi: 10.1182/blood-2011-12-395707. Epub 2012 Mar 8.
Blood. 2012.
PMID: 22403254
Free PMC article.